Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury.

Di Pietro V, Amorini AM, Lazzarino G, Yakoub KM, D'Urso S, Lazzarino G, Belli A.

Neurochem Res. 2015 May;40(5):991-9. doi: 10.1007/s11064-015-1554-9. Epub 2015 Apr 22.

PMID:
25898931
2.

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H.

J Neurotrauma. 2004 Nov;21(11):1553-61.

PMID:
15684648
3.

[Expression of S100B and GFAP after primary brainstem injury in rat].

Wu YH, Wang HJ, Wang X.

Fa Yi Xue Za Zhi. 2015 Feb;31(1):11-4. Chinese.

PMID:
26058126
4.

Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.

Welch RD, Ellis M, Lewis LM, Ayaz SI, Mika VH, Millis S, Papa L.

J Neurotrauma. 2017 Jun 1;34(11):1957-1971. doi: 10.1089/neu.2016.4772. Epub 2017 Feb 27.

PMID:
28031000
5.

In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography.

Papa L, Mittal MK, Ramirez J, Ramia M, Kirby S, Silvestri S, Giordano P, Weber K, Braga CF, Tan CN, Ameli NJ, Lopez M, Zonfrillo M.

J Neurotrauma. 2016 Jan 1;33(1):58-64. doi: 10.1089/neu.2015.3869. Epub 2015 Jun 3.

6.

Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.

Welch RD, Ayaz SI, Lewis LM, Unden J, Chen JY, Mika VH, Saville B, Tyndall JA, Nash M, Buki A, Barzo P, Hack D, Tortella FC, Schmid K, Hayes RL, Vossough A, Sweriduk ST, Bazarian JJ.

J Neurotrauma. 2016 Jan 15;33(2):203-14. doi: 10.1089/neu.2015.4149. Epub 2015 Dec 18.

7.

Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.

Huang XJ, Glushakova O, Mondello S, Van K, Hayes RL, Lyeth BG.

J Neurotrauma. 2015 Aug 15;32(16):1179-89. doi: 10.1089/neu.2015.3873. Epub 2015 May 14.

PMID:
25763798
8.

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.

Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM.

Neurology. 2004 Apr 27;62(8):1303-10.

PMID:
15111666
9.

Multiple indicators model of long-term mortality in traumatic brain injury.

Gradisek P, Osredkar J, Korsic M, Kremzar B.

Brain Inj. 2012;26(12):1472-81. doi: 10.3109/02699052.2012.694567. Epub 2012 Jun 21.

PMID:
22721420
10.

Effects of hypothermia on S100B and glial fibrillary acidic protein in asphyxia rats after cardiopulmonary resuscitation.

Liu S, Zhang Y, Zhao Y, Cui H, Cao C, Guo J.

Cell Biochem Biophys. 2015 Jan;71(1):401-6. doi: 10.1007/s12013-014-0212-1.

PMID:
25209741
11.

GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

Papa L, Silvestri S, Brophy GM, Giordano P, Falk JL, Braga CF, Tan CN, Ameli NJ, Demery JA, Dixit NK, Mendes ME, Hayes RL, Wang KK, Robertson CS.

J Neurotrauma. 2014 Nov 15;31(22):1815-22. doi: 10.1089/neu.2013.3245. Epub 2014 Sep 12.

12.

Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.

Petzold A, Eikelenboom MJ, Gveric D, Keir G, Chapman M, Lazeron RH, Cuzner ML, Polman CH, Uitdehaag BM, Thompson EJ, Giovannoni G.

Brain. 2002 Jul;125(Pt 7):1462-73.

PMID:
12076997
13.

The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.

Akdemir HU, Yardan T, Kati C, Duran L, Alacam H, Yavuz Y, Okuyucu A.

Hum Exp Toxicol. 2014 Nov;33(11):1113-20. doi: 10.1177/0960327114521049. Epub 2014 Feb 6.

PMID:
24505052
14.

Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.

McMahon PJ, Panczykowski DM, Yue JK, Puccio AM, Inoue T, Sorani MD, Lingsma HF, Maas AI, Valadka AB, Yuh EL, Mukherjee P, Manley GT, Okonkwo DO; TRACK-TBI Investigators.

J Neurotrauma. 2015 Apr 15;32(8):527-33. doi: 10.1089/neu.2014.3635. Epub 2015 Jan 26.

15.

Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.

Mondello S, Kobeissy F, Vestri A, Hayes RL, Kochanek PM, Berger RP.

Sci Rep. 2016 Jun 20;6:28203. doi: 10.1038/srep28203.

16.

GFAP and S100B in the acute phase of mild traumatic brain injury.

Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J.

Neurology. 2012 May 1;78(18):1428-33. doi: 10.1212/WNL.0b013e318253d5c7. Epub 2012 Apr 18.

PMID:
22517109
17.

Vimentin and GFAP responses in astrocytes after contusion trauma to the murine brain.

Ekmark-Lewén S, Lewén A, Israelsson C, Li GL, Farooque M, Olsson Y, Ebendal T, Hillered L.

Restor Neurol Neurosci. 2010;28(3):311-21. doi: 10.3233/RNN-2010-0529.

PMID:
20479526
18.

Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury.

Boutté AM, Deng-Bryant Y, Johnson D, Tortella FC, Dave JR, Shear DA, Schmid KE.

J Neurotrauma. 2016 Jan 1;33(1):147-56. doi: 10.1089/neu.2014.3672. Epub 2015 Jun 8.

PMID:
25789543
19.

Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.

Bogoslovsky T, Wilson D, Chen Y, Hanlon D, Gill J, Jeromin A, Song L, Moore C, Gong Y, Kenney K, Diaz-Arrastia R.

J Neurotrauma. 2017 Jan 1;34(1):66-73. doi: 10.1089/neu.2015.4333. Epub 2016 Jul 8.

20.

In vitro MS-based proteomic analysis and absolute quantification of neuronal-glial injury biomarkers in cell culture system.

Guingab-Cagmat JD, Newsom K, Vakulenko A, Cagmat EB, Kobeissy FH, Zoltewicz S, Wang KK, Anagli J.

Electrophoresis. 2012 Dec;33(24):3786-97. doi: 10.1002/elps.201200326.

PMID:
23161537

Supplemental Content

Support Center